Molecular Pathology

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Moussad, E E-D A
Right arrow Articles by Brigstock, D R
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Moussad, E E-D A
Right arrow Articles by Brigstock, D R
Molecular Pathology 2002;55:186-192
© 2002 Journal of Clinical Pathology


ORIGNAL ARTICLE

Temporal and spatial expression of connective tissue growth factor (CCN2; CTGF) and transforming growth factor ß type 1 (TGF-ß1) at the utero–placental interface during early pregnancy in the pig

E E-D A Moussad1, M A E Rageh1, A K Wilson1, R D Geisert2 and D R Brigstock1

1 Department of Surgery, Children's Research Institute, Children's Hospital and The Ohio State University, Columbus OH 43205, USA
2 Department of Animal Science, Oklahoma Agricultural Experiment Station, Oklahoma State University, Stillwater OK 74078, USA

Correspondence to:
Dr D Brigstock, Children's Research Institute, 700 Children's Drive, Columbus OH43205, USA;
Brigstod{at}pediatrics.ohio-state.edu


ABSTRACT
Aims: To determine the localisation and distribution of connective tissue growth factor (CCN2; CTGF) and transforming growth factor ß type 1 (TGF-ß1) in uterine tissues from cycling and early pregnant pigs.

Methods: In situ hybridisation and immunohistochemistry were used to localise CCN2 (CTGF) or TGF-ß1 in uteri obtained from gilts on days 0, 5, 10, 12, 15, and 18 of the oestrous cycle or days 10, 12, 14, 16, 17, and 21 of gestation.

Results: In cycling animals, CCN2 (CTGF) mRNA and protein were abundant in luminal epithelial cells (LECs) and glandular epithelial cells (GECs), with lesser amounts in stromal fibroblasts and little or none in endothelial cells. A similar pattern of staining was seen up to day 10 of pregnancy, except that overall staining intensities for CCN2 (CTGF) mRNA or protein were higher and that stromal and endothelial cells were CCN2 (CTGF) positive. However, on days 12–17 there was a striking decrease in the amount of CCN2 (CTGF) in LECs at the utero–conceptus interface, which was associated with maternal stromal matrix reorganisation and the onset of subepithelial neovascularisation. This differential distribution of CCN2 (CTGF) was localised to those LECs that were in close proximity to or in apposition with trophoblast cells. This decrease in CCN2 (CTGF) staining was transient in nature and high amounts of CCN2 (CTGF) were again apparent in LECs on days 17–21, when endometrial neovascularisation and matrix remodelling were complete. The expression of uterine TGF-ß1 was comparable to that of CCN2 (CTGF) at most stages of the oestrous cycle or early pregnancy. Pre-elongation blastocysts recovered on day 10 were positive for both CCN2 (CTGF) and TGF-ß1 in the extra-embryonic trophectoderm, endoderm, and inner cell mass. On day 12, trophectoderm expressed low amounts of TGF-ß1 mRNA and non-detectable amounts of TGF-ß1 protein or CCN2 (CTGF) mRNA or protein. By days 17–21, the expression of both growth factors in the extra-embyronic/placental membranes increased and frequently exceeded that seen in LECs.

Conclusions: The pattern of CCN2 (CTGF) production during the initial attachment phase supports a role for this factor in stromal remodelling and neovascularisation, although alternative functions at later stages such as epithelial–epithelial interactions are also possible. In most major cell types in the uterus or utero–placental unit, CCN2 (CTGF) expression was highly correlated with that of TGF-ß1, indicating that CCN2 (CTGF) may mediate some of the functions of TGF-ß in the reproductive tract during the oestrous cycle and pregnancy. The data further highlight epithelium as an important source of CCN2 (CTGF) in the regulation of uterine function.


Keywords: placenta; angiogenesis; extracellular matrix; epithelium; endothelium; CCN2 (CTGF)

Abbreviations: BSA, bovine serum albumin; CCN2/CTGF, connective tissue growth factor; ECM, extracellular matrix; FGF, fibroblast growth factor; GECs, glandular epithelial cells; LECs, luminal epithelial cells; PBS, phosphate buffered saline; TGF-ß1, transforming growth factor ß type 1




This article has been cited by other articles:


Home page
Biol. Reprod.Home page
C. Klein, S. Bauersachs, S. E. Ulbrich, R. Einspanier, H. H.D. Meyer, S. E.M. Schmidt, H.-D. Reichenbach, M. Vermehren, F. Sinowatz, H. Blum, et al.
Monozygotic Twin Model Reveals Novel Embryo-Induced Transcriptome Changes of Bovine Endometrium in the Preattachment Period
Biol Reprod, February 1, 2006; 74(2): 253 - 264.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
A W Rachfal, M H Luquette, and D R Brigstock
Expression of connective tissue growth factor (CCN2) in desmoplastic small round cell tumour
J. Clin. Pathol., April 1, 2004; 57(4): 422 - 425.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Molecular Pathology Journal of Clinical Pathology
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2002 by the BMJ Publishing Group Ltd & Association of Clinical Pathologists.